Alvolab
Alvolab provides validated preclinical models to accelerate kidney disease therapy development. They conduct in vivo imaging (IVIS, μCT, PET/MRI), histology with AI-assisted scoring, spatial and single-cell transcriptomics, proteomics, and biomarker analysis. As a spin-off from Karolinska Institutet, they partner with biotech, pharma, and academic groups. They operate as a preclinical CRO, offering comprehensive data and reproducible workflows. The company aims to scale translational research for AKI, CKD, and diabetic nephropathy.
Alvolab
Alvolab provides validated preclinical models to accelerate kidney disease therapy development. They conduct in vivo imaging (IVIS, μCT, PET/MRI), histology with AI-assisted scoring, spatial and single-cell transcriptomics, proteomics, and biomarker analysis. As a spin-off from Karolinska Institutet, they partner with biotech, pharma, and academic groups. They operate as a preclinical CRO, offering comprehensive data and reproducible workflows. The company aims to scale translational research for AKI, CKD, and diabetic nephropathy.